Additionally, we comprehensively investigated the correlations between GNGT1 expression and key factors, such as tumour immune microenvironment features, immune cell gene marker expression, immune checkpoint expression and drug sensitivity, on the basis of multigroup bioinformatics and clinical cohort data. This evidence concerns the gene GNGT1 and neoplasm.